SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950133-01-000155
Filing Date
2001-01-19
Accepted
2001-01-19 00:00:00
Documents
5
Period of Report
2001-01-08
Items
Item 2: Acquisition or disposition of assets
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K w44469e8-k.txt 8-K 4729
2 AGREEMENT FOR PURCHASE AND SALE OF ASSETS w44469ex10-1.txt EX-10.1 78066
3 COPROMOTION AGREEMENT w44469ex10-2.txt EX-10.2 165445
4 EXCLUSIVE LICENSE AND DISTRIBUTION AGREEMENT w44469ex10-3.txt EX-10.3 90137
5 PRESS RELEASE w44469ex99-1.txt EX-99.1 8452
  Complete submission text file 0000950133-01-000155.txt   348902
Mailing Address 8320 GUILFORD ROAD SUITE C 12111 PARKLAWN DR COLUMBIA MD 21046
Business Address 8320 GUILFORD RD STE C COLUMBIA MD 21046 3078543900
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 1511599
SIC: 2836 Biological Products, (No Diagnostic Substances)